Inolex, a prominent leader in beauty care ingredients on a global scale, has recently been awarded a European patent for its pioneering safe and sustainable preservation technology. The company’s newest patent is centered around paraben-free multifunctional compositions for topical cosmetic, toiletry, and pharmaceutical formulations. This technology utilizes Caprylhydroxamic Acid (CHA) in conjunction with a vicinal diol to safeguard against microbiological growth, eliminating the need for harmful preservatives.
A notable addition to Inolex’s array of preservation products is the launch of Spectrastat™ CHA, a 100% natural, non-palm derived chelating agent in powder form. This innovative product offers a sustainable solution for formulators seeking to create effective preservation systems using Caprylhydroxamic Acid. The combination of CHA with a vicinal diol, such as Caprylyl Glycol, Glyceryl Caprylate, and Caprylyl Glyceryl Ether, has been demonstrated to be crucial for ensuring product protection, as emphasized in Inolex’s recently granted patent.
Dr. Michael J. Fevola, Vice President of Research and Development at Inolex, articulated that Inolex’s preservation technology employs the hurdle technology approach, which integrates various preservation factors to achieve broad-spectrum and dependable preservation effects. The introduction of Spectrastat™ CHA presents maximum flexibility, allowing microbiologists and formulators the opportunity to work with individual ingredients when crafting their preservation systems. The coconut-derived organic acid and chelating agent remains effective at neutral pH levels and inhibits the growth of yeast and mold in formulations.
Beyond furnishing individual multifunctional components, Inolex’s range also accommodates formulators who prefer pre-optimized combinations to streamline supply chain complexity. The Spectrastat™ line offers CHA and vicinal diols in optimized ratios for superior preservation efficacy, with added carriers for formulation convenience. Furthermore, formulators have the option of combining Spectrastat™ CHA with an MCTD from Inolex’s Lexgard® line to attain broad-spectrum preservation efficacy. The Lexgard® series of ingredients offers supplementary benefits based on specific formulation requirements.
Inolex’s patented compositions and methods yield a versatile ingredient platform, affording formulators the flexibility to develop their ideal preservation system for consumer products without ambiguity. Whether through pre-optimized combinations or individual ingredients, Inolex’s innovative technology platform equips formulators with the requisite tools to meet their unique needs.
For further details on Inolex’s proprietary, secure, and sustainable preservation platform, please visit www.inolex.com.
Reference:
European patent EP3075401B1 Title: Caprylhydroxamic Acid as preservation for cosmetics, toiletry, and pharmaceutical compositions.